Skip to content
OpenCapital
Get started

Bio-Rad Laboratories, Inc. BIO.B SG&A

SG&A at other companies

Abbott logo
AbbottABT
$3.74B+22.2%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$1.21B+8.6%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$2.18B+5.0%
Danaher logo
DanaherDHR
$1.86B+0.1%
Agilent Technologies logo
Agilent TechnologiesA
$465M+2.4%
Revvity logo
RevvityRVTY
$253.88M+1.7%

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×—
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s SG&A?
Bio-Rad Laboratories, Inc. (BIO.B) reported SG&A of $212.4M in Q1 2026.
How has Bio-Rad Laboratories, Inc.'s SG&A changed year-over-year?
Bio-Rad Laboratories, Inc.'s SG&A increased by 1.7% year-over-year, from $208.8M to $212.4M.
What is the long-term trend for Bio-Rad Laboratories, Inc.'s SG&A?
Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s SG&A has grown at a -0.9% compound annual growth rate (CAGR), from $877.12M to $844.3M.
What does SG&A mean?
Selling, general, and administrative expenses represent the costs associated with operating the business that are not directly tied to production. This includes salaries for non-manufacturing staff, marketing, office rent, and legal fees. It reflects the company's overhead structure and investment in commercial infrastructure.